Stock listing
NASDAQ:NAMS NewAmsterdam Pharma Company N.V. Stock
Home listing (NASDAQ) of NewAmsterdam Pharma Company N.V.
Follow NewAmsterdam Pharma Company N.V. into a list and get an email when it puts out news.
Share price · NASDAQ:NAMS
$19.71 USD -1.87 (-8.7%)
Close on Oct 23, 2026
- Day range
- $19.13 – $21.39 USDOct 23, 2026
- Volume
- 2.31M sharesOct 23, 2026
- Market cap
- $2.36B USDAt the close on Oct 23, 2026 · price × 119.5M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NAMS · Home | $19.71 USD | -1.87 (-8.7%) | 2,311,178 | $21.39 | $21.39 | $19.13 | $21.58 | Close on Oct 23, 2026 |
| Dusseldorf:KH6 | €18.48 EUR | -0.745 (-3.9%) | — | €18.89 | €18.89 | €18.48 | €19.23 | Close on Oct 23, 2026 |
| Frankfurt:KH6 | €18.54 EUR | +0.025 (+0.1%) | — | €18.31 | €18.54 | €18.31 | €18.51 | Close on Oct 23, 2026 |
Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · NASDAQ:NAMS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $19.71 | -1.87 | -8.7% | $21.39 | $21.39 | $19.13 | 2,311,178 | |
| $21.58 | +0.09 | +0.4% | $21.25 | $22.25 | $21.25 | 1,703,550 | |
| $21.49 | -0.01 | 0.0% | $21.58 | $22.28 | $21.31 | 1,252,575 | |
| $21.50 | +1.03 | +5.0% | $20.57 | $21.94 | $20.47 | 1,075,468 | |
| $20.47 | +0.64 | +3.2% | $19.99 | $20.57 | $19.85 | 724,786 | |
| $19.83 | -0.79 | -3.8% | $20.51 | $20.67 | $19.71 | 1,937,146 | |
| $20.62 | +0.61 | +3.0% | $20.30 | $21.12 | $20.21 | 881,932 | |
| $20.01 | -0.18 | -0.9% | $20.08 | $20.75 | $19.58 | 2,191,245 | |
| $20.19 | -1.06 | -5.0% | $21.20 | $21.34 | $20.04 | 978,164 | |
| $21.25 | -0.325 | -1.5% | $21.28 | $21.97 | $21.04 | 812,288 | |
| $21.58 | +0.315 | +1.5% | $21.25 | $21.79 | $21.02 | 1,265,995 | |
| $21.26 | -0.87 | -3.9% | $22.00 | $22.13 | $20.91 | 1,665,052 | |
| $22.13 | -0.14 | -0.6% | $22.07 | $22.72 | $21.85 | 1,378,849 | |
| $22.27 | -0.53 | -2.3% | $23.06 | $23.11 | $21.44 | 1,266,200 | |
| $22.80 | -0.40 | -1.7% | $22.84 | $23.34 | $22.23 | 1,182,300 | |
| $23.20 | -0.96 | -4.0% | $24.60 | $24.75 | $22.67 | 1,547,700 | |
| $24.16 | -0.16 | -0.7% | $24.23 | $24.84 | $24.06 | 1,628,300 | |
| $24.32 | +0.51 | +2.1% | $24.00 | $25.12 | $23.96 | 2,270,400 | |
| $23.81 | +0.23 | +1.0% | $23.52 | $24.54 | $23.26 | 1,074,600 | |
| $23.58 | +1.00 | +4.4% | $22.50 | $24.21 | $22.25 | 2,056,700 | |
| $22.58 | -0.16 | -0.7% | $22.93 | $22.96 | $22.35 | 1,136,000 | |
| $22.74 | +0.06 | +0.3% | $22.47 | $23.19 | $21.95 | 1,824,200 | |
| $22.68 | -0.64 | -2.7% | $23.31 | $23.32 | $22.08 | 2,265,300 | |
| $23.32 | +0.74 | +3.3% | $22.91 | $23.73 | $22.13 | 2,869,200 | |
| $22.58 | +0.09 | +0.4% | $22.95 | $23.20 | $21.68 | 3,529,800 | |
| $22.49 | +0.56 | +2.6% | $21.62 | $22.50 | $21.29 | 2,076,400 | |
| $21.93 | +0.75 | +3.5% | $21.59 | $23.11 | $21.46 | 2,310,500 | |
| $21.18 | +0.02 | +0.1% | $22.07 | $22.15 | $21.02 | 1,238,400 | |
| $21.16 | -1.20 | -5.4% | $22.32 | $22.63 | $21.08 | 1,732,700 | |
| $22.36 | -0.44 | -1.9% | $22.96 | $22.96 | $22.34 | 1,079,000 | |
| $22.80 | +0.94 | +4.3% | $22.11 | $23.00 | $21.23 | 1,596,500 | |
| $21.86 | -0.93 | -4.1% | $22.44 | $22.95 | $21.80 | 2,728,800 | |
| $22.79 | -2.84 | -11.1% | $25.35 | $25.53 | $22.34 | 2,318,000 | |
| $25.63 | +0.23 | +0.9% | $24.02 | $26.19 | $23.24 | 3,801,400 | |
| $25.40 | -0.45 | -1.7% | $25.65 | $25.75 | $25.10 | 709,500 | |
| $25.85 | +0.26 | +1.0% | $25.68 | $25.99 | $25.24 | 581,300 | |
| $25.59 | +0.67 | +2.7% | $25.15 | $26.01 | $25.00 | 979,900 | |
| $24.92 | -0.42 | -1.7% | $25.27 | $25.43 | $24.80 | 714,400 | |
| $25.34 | -0.56 | -2.2% | $25.65 | $25.65 | $24.80 | 1,546,200 | |
| $25.90 | -0.89 | -3.3% | $26.66 | $26.88 | $25.53 | 1,036,000 | |
| $26.79 | -0.61 | -2.2% | $27.15 | $27.60 | $26.67 | 626,800 | |
| $27.40 | +0.06 | +0.2% | $27.22 | $27.61 | $26.71 | 758,700 | |
| $27.34 | +0.49 | +1.8% | $27.00 | $28.01 | $27.00 | 1,986,400 | |
| $26.85 | -1.02 | -3.7% | $27.80 | $27.97 | $26.67 | 1,154,200 | |
| $27.87 | +0.09 | +0.3% | $27.99 | $28.35 | $27.66 | 525,400 | |
| $27.78 | -0.75 | -2.6% | $28.26 | $28.43 | $27.53 | 744,400 | |
| $28.53 | +1.28 | +4.7% | $28.00 | $28.76 | $27.64 | 1,032,200 | |
| $27.25 | +0.35 | +1.3% | $26.66 | $27.82 | $26.43 | 948,900 | |
| $26.90 | -0.08 | -0.3% | $26.93 | $27.39 | $26.51 | 834,900 | |
| $26.98 | +0.31 | +1.2% | $26.26 | $27.06 | $26.01 | 959,700 | |
| $26.67 | -1.16 | -4.2% | $27.85 | $28.03 | $26.63 | 1,225,400 | |
| $27.83 | +0.21 | +0.8% | $27.95 | $28.18 | $27.45 | 1,627,500 | |
| $27.62 | -0.36 | -1.3% | $27.95 | $28.63 | $27.29 | 2,343,100 | |
| $27.98 | +0.02 | +0.1% | $28.08 | $28.97 | $27.43 | 901,800 | |
| $27.96 | +0.29 | +1.0% | $28.05 | $28.23 | $27.51 | 572,000 | |
| $27.67 | +0.25 | +0.9% | $27.63 | $27.98 | $27.30 | 1,649,400 | |
| $27.42 | -0.13 | -0.5% | $27.33 | $27.85 | $25.74 | 1,652,600 | |
| $27.55 | +0.06 | +0.2% | $27.82 | $28.06 | $27.00 | 1,080,400 | |
| $27.49 | -0.30 | -1.1% | $27.67 | $27.89 | $26.91 | 1,012,500 | |
| $27.79 | -0.67 | -2.4% | $28.37 | $28.76 | $27.31 | 956,600 | |
| $28.46 | +0.55 | +2.0% | $27.93 | $28.72 | $26.99 | 611,400 | |
| $27.91 | -0.07 | -0.3% | $28.25 | $29.13 | $27.44 | 1,301,200 | |
| $27.98 | -2.24 | -7.4% | $30.06 | $30.28 | $27.81 | 890,500 | |
| $30.22 | +0.58 | +2.0% | $30.11 | $31.29 | $30.10 | 948,700 | |
| $29.64 | -0.91 | -3.0% | $30.87 | $31.17 | $29.61 | 1,093,300 | |
| $30.55 | -1.15 | -3.6% | $30.66 | $31.31 | $30.14 | 872,000 |
- Ticker
- NASDAQ:NAMS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 2, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest earnings call · Aug 5, 2026
Newamsterdam Pharma (NASDAQ:NAMS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Investor Presentation (August 2026)
Investor deck · 40 slides
Calls
Replays
Newamsterdam Pharma (NASDAQ:NAMS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 9:00 AM ET
Watch TranscriptNewamsterdam Pharma (NASDAQ:NAMS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:00 AM ET
Watch Transcript
Latest news
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $22.80 (-1.7%) on Oct 5, 2026
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
Sep 29, 2026
Closed $23.81 (+1.0%) on Sep 29, 2026
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Sep 21, 2026
Closed $22.58 (+0.4%) on Sep 21, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
Sep 2, 2026
Closed $25.59 (+2.7%) on Sep 2, 2026
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
Aug 26, 2026
Closed $27.40 (+0.2%) on Aug 26, 2026
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
Jul 29, 2026
Closed $27.91 (-0.3%) on Jul 29, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 40 slides · Aug 10, 2026
Investor Day (August 2026)
Investor day · 143 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 6 slides · May 7, 2026
Investor Presentation (March 2026)
Investor deck · 38 slides · Mar 2, 2026
NewAmsterdam Pharma Company N.V. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 90 in all · newest Oct 2, 2026 · oldest 2022
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 5, 2026
- Decks
- 32 decks · latest Aug 10, 2026
Where NewAmsterdam Pharma Company N.V. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NAMS · Home listing · This page | NASDAQ | United States | USD |
| gettex:KH6 | gettex | Germany | EUR |
| LS Exchange:A3DUAC | LS Exchange | Germany | EUR |
| Tradegate:KH6 | Tradegate | Germany | EUR |
| BOATS:NAMS | BOATS | United States | USD |
| Lang & Schwarz:A3DUAC | Lang & Schwarz | Germany | EUR |
| Dusseldorf:KH6 | Dusseldorf | Germany | EUR |
| Frankfurt:KH6 | Frankfurt | Germany | EUR |
| Hamburg:KH6 | Hamburg | Germany | EUR |
| Munich:KH6 | Munich | Germany | EUR |
| Stuttgart:KH6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about NewAmsterdam Pharma Company N.V.